文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

KDM3B通过LOX的m6A修饰调控前列腺基质放疗后纤维化反应

KDM3B Regulates Postradiation Fibrotic Responses in Prostate Stroma via N6-methyladenosine Modification of LOX.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2025-06-28

该研究探索KDM3B基因SNP rs17599026与前列腺癌放疗后晚期泌尿毒性关联的机制。采用prime editing模拟变异的前列腺基质细胞及野生型/杂合型Kdm3b小鼠模型,发现该SNP经circRNA/miRNA机制降低KDM3B蛋白,减少LOX mRNA的m6A修饰并增强其稳定性,促进胶原交联与纤维化;补充α-酮戊二酸可恢复KDM3B、降低LOX并减轻纤维化。

要点

  • KDM3B SNP rs17599026降低KDM3B蛋白,经m6A途径稳定LOX mRNA促纤维化。
  • α-酮戊二酸补充可恢复KDM3B蛋白并减轻体外及体内放疗后纤维化。
  • 该机制为前列腺癌放疗毒性提供潜在干预靶点,尚需临床验证。

核心结论

  • KDM3B遗传变异通过LOX的转录后调控影响放疗诱导的纤维化。
  • 膳食α-酮戊二酸补充可能作为减轻前列腺癌患者放疗毒性的机制性策略。

研究设计与样本

  • 使用CRISPR-dead Cas9 prime editing系统在前列腺基质细胞系中模拟KDM3B遗传变异。
  • 采用野生型和杂合型Kdm3b基因型小鼠模型评估放疗后纤维化。
  • 通过RNA免疫沉淀、转录本稳定性实验和蛋白分析阐明m6A修饰对LOX表达的调控。
  • 测试α-酮戊二酸补充对KDM3B蛋白稳定性、LOX表达及纤维化的影响。

主要发现

  • rs17599026 SNP通过circRNA和miRNA介导的机制降低KDM3B蛋白表达。
  • KDM3B降低导致LOX mRNA的m6A修饰减少、稳定性增加。
  • LOX表达升高促进前列腺基质中胶原交联和纤维化。
  • α-酮戊二酸补充在体外和体内恢复KDM3B蛋白水平、降低LOX表达并减轻纤维化。

关键数值与推荐

  • SNP rs17599026位于KDM3B基因内含子21,与放疗后2年排尿频率增加(晚期泌尿毒性)相关。

临床怎么用

  • 对携带KDM3B rs17599026变异的前列腺癌放疗患者,可关注晚期泌尿毒性风险。
  • α-酮戊二酸补充作为减轻放疗后纤维化的潜在策略,目前仅为临床前证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Genome-wide association studies have uncovered single-nucleotide polymorphisms (SNPs) linked to radiation therapy (RT)-induced toxicities in patients with prostate cancer. SNP rs17599026, located in intron 21 of the KDM3B gene, has been associated with late-onset urinary toxicity, with an increased frequency of urination observed 2 years post-RT compared with pretreatment conditions. This study aimed to explore the underlying mechanisms driving this association. METHODS AND MATERIALS: A clustered regularly interspaced short palindromic repeats-dead Cas9 prime editing system was used to mimic KDM3B genetic variants in prostate stromal cell lines. Murine models with wild-type and heterozygous Kdm3b genotypes were used to assess fibrosis following radiation. RNA immunoprecipitation, transcript stability assays, and protein analysis elucidated the role of N6-methyladenosine (m6A) modification in regulating lysyl oxidase (LOX) expression. α-ketoglutarate (α-KG) supplementation was tested for its effects on KDM3B protein stability, LOX expression, and fibrosis mitigation. RESULTS: The rs17599026 SNP reduced KDM3B protein expression via circular RNA and microRNA-mediated mechanisms, leading to decreased m6A modification and increased stability of LOX messenger RNA. Elevated LOX expression promoted collagen cross-linking and fibrosis in prostate stroma. α-KG supplementation restored KDM3B protein levels, reduced LOX expression, and mitigated fibrosis in vitro and in vivo. CONCLUSIONS: KDM3B genetic variations influence radiation-induced fibrosis through posttranscriptional regulation of LOX. Dietary α-KG supplementation may serve as a mechanism-based strategy to alleviate radiation toxicity in patients with prostate cancer, offering a potential therapeutic pathway to improve treatment outcomes.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Dong A, Sun X, Chen L, et al. KDM3B Regulates Postradiation Fibrotic Responses in Prostate Stroma via N6-methyladenosine Modification of LOX. Int J Radiat Oncol Biol Phys. 2025. PMID: 40588066. doi:10.1016/j.ijrobp.2025.06.3851

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。